Cardinal Health, Inc. CAH
- Market cap
- $51.6B
- P/E
- 30.3×
Follow CAH
Cardinal Health, Inc. (CAH) Return on invested capital
Cardinal Health, Inc.'s return on invested capital over the twelve months to 30 June 2026 was 125.1%. Over the past ten years it has ranged from −44.2% (fiscal 2020) to 125.1% (fiscal 2026) — the current reading is the highest in ten years. That is above the Medical Distribution industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Annual
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2026 | 125.1% | 54.63 |
| FY2025 | 70.4% | 70.42 |
| FY2024 | 0.00% | 0.00 |
| FY2023 | 0.00% | 0.00 |
| FY2022 | 0.00% | (6.38) |
| FY2021 | 6.38% | 50.57 |
| FY2020 | −44.2% | (55.07) |
| FY2019 | 10.9% | 10.29 |
| FY2018 | 0.59% | (12.22) |
| FY2017 | 12.8% | (2.95) |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| CAH Cardinal Health, Inc. | 125.1% |
| MCK McKesson Corporation compare | 70.5% |
| COR Cencora, Inc. compare | 15.7% |
| HSIC Henry Schein, Inc. compare | 6.97% |
| ACH Accendra Health, Inc. compare | 1.58% |
| YI 111, Inc. Sponsored ADR compare | 0.00% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| COSM Cosmos Health Inc. compare | −38.2% |
| FOCL FocalTherics compare | −110.8% |
| Medical Distribution industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on CAH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement